APA (7th ed.) Citation

AB, R., AN, O., OA, O., NW, E., D, B., OA, O., . . . JN, O. (2022). RHAMNETIN IS A BETTER INHIBITOR OF SARS-COV-2 2'-O-METHYLTRANSFERASE THAN DOLUTEGRAVIR: A COMPUTATIONAL PREDICTION. African journal of infectious diseases, 16(2), 80. https://doi.org/10.21010/Ajid.v16i2.9

Chicago Style (17th ed.) Citation

AB, Rowaiye, et al. "RHAMNETIN IS A BETTER INHIBITOR OF SARS-COV-2 2'-O-METHYLTRANSFERASE THAN DOLUTEGRAVIR: A COMPUTATIONAL PREDICTION." African Journal of Infectious Diseases 16, no. 2 (2022): 80. https://doi.org/10.21010/Ajid.v16i2.9.

MLA (9th ed.) Citation

AB, Rowaiye, et al. "RHAMNETIN IS A BETTER INHIBITOR OF SARS-COV-2 2'-O-METHYLTRANSFERASE THAN DOLUTEGRAVIR: A COMPUTATIONAL PREDICTION." African Journal of Infectious Diseases, vol. 16, no. 2, 2022, p. 80, https://doi.org/10.21010/Ajid.v16i2.9.